DongKoo Bio & Pharma Co. Ltd. Net Asset Quality Index
DongKoo Bio & Pharma Co. Ltd. net asset quality index. DongKoo Bio & Pharma Co. Ltd. (006620) has a Net Asset Quality Index of 44.8% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of ₩318.60 Billion minus total liabilities of ₩176.02 Billion yields net assets of ₩142.58 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See DongKoo Bio & Pharma Co. Ltd. book value and equity for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of DongKoo Bio & Pharma Co. Ltd. (2015–2025)
Net asset quality index of DongKoo Bio & Pharma Co. Ltd. from 2015 to 2025. This chart shows how DongKoo Bio & Pharma Co. Ltd.'s Net Asset Quality Index has evolved across 11 annual periods from 2015 to 2025. As of June 2026, the index stands at 44.8%, representing net assets of ₩142.58 Billion against total assets of ₩318.60 Billion KRW. Check 006620 strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
DongKoo Bio & Pharma Co. Ltd. Net Asset Quality Index by Year (2015–2025)
DongKoo Bio & Pharma Co. Ltd. net asset quality index by year from 2015 to 2025. The table below presents the year-by-year Net Asset Quality Index for DongKoo Bio & Pharma Co. Ltd. from 2015 to 2025, covering 11 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see 006620 company net worth.
| Year | Quality Index | Net Assets (KRW) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 45.2% | ₩152.16 Billion | ₩336.35 Billion | ₩184.19 Billion | ▲ +2.1 pp |
| 2024 | 43.2% | ₩105.33 Billion | ₩244.06 Billion | ₩138.73 Billion | ▼ -14.6 pp |
| 2023 | 57.8% | ₩110.44 Billion | ₩191.10 Billion | ₩80.66 Billion | ▼ -1.6 pp |
| 2022 | 59.3% | ₩102.11 Billion | ₩172.06 Billion | ₩69.95 Billion | ▼ -5.3 pp |
| 2021 | 64.7% | ₩100.12 Billion | ₩154.79 Billion | ₩54.66 Billion | ▼ -0.9 pp |
| 2020 | 65.6% | ₩94.65 Billion | ₩144.35 Billion | ₩49.70 Billion | ▲ +1.0 pp |
| 2019 | 64.5% | ₩85.65 Billion | ₩132.73 Billion | ₩47.07 Billion | ▼ -4.6 pp |
| 2018 | 69.1% | ₩72.10 Billion | ₩104.28 Billion | ₩32.18 Billion | ▲ +19.2 pp |
| 2017 | 49.9% | ₩37.74 Billion | ₩75.59 Billion | ₩37.85 Billion | ▲ +16.2 pp |
| 2016 | 33.8% | ₩22.05 Billion | ₩65.31 Billion | ₩43.27 Billion | ▲ +29.6 pp |
| 2015 | 4.2% | ₩2.55 Billion | ₩60.77 Billion | ₩58.22 Billion | — |